Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors.
about
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesEndometriosis: where are we and where are we going?Is endometriosis a preneoplastic condition?Endometriosis and ovarian cancer: links, risks, and challenges facedEndometriosis and ovarian cancer risk: a systematic review of epidemiological studiesThe exposome--exciting opportunities for discoveries in reproductive and perinatal epidemiologyWorld Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research.Antioxidant enzymes and lipid peroxidation in endometrium of patients with polyps, myoma, hyperplasia and adenocarcinoma.Malignant neoplasia arising from ovarian remnants following bilateral salpingo-oophorectomy (Review).Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer.Markers of inflammation and risk of ovarian cancer in Los Angeles CountyOvarian cancer risk after salpingectomy: a nationwide population-based study.An increased risk of epithelial ovarian cancer in Taiwanese women with a new surgico-pathological diagnosis of endometriosisIncreased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort studyInfertility and incident endometrial cancer risk: a pooled analysis from the epidemiology of endometrial cancer consortium (E2C2).Endometriosis as a risk factor for ovarian or endometrial cancer - results of a hospital-based case-control study.History of uterine leiomyomata and incidence of breast cancer.Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control studyRelationships of uterine and ovarian tumors to pre-existing chronic conditions.The etiology of uterine sarcomas: a pooled analysis of the epidemiology of endometrial cancer consortium.History of uterine leiomyoma and risk of endometrial cancer in black women.Endometriosis-associated ovarian cancer: a review of pathogenesisPolymorphisms in inflammation pathway genes and endometrial cancer riskDifferential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro.ARID1A mutations and PI3K/AKT pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas.Risk of epithelial ovarian cancer in relation to benign ovarian conditions and ovarian surgery.Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.Endometriosis and ovarian cancer: a review.Ovarian cancer in endometriosis: clinical and molecular aspects.Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis.Benign breast and gynecologic conditions, reproductive and hormonal factors, and risk of thyroid cancer.Epidemiology of ovarian cancer: a review.The relation between endometriosis and ovarian cancer - a review.Clear cell carcinoma of ovary and uterus.Endometriosis and cancer.Outcomes of fertility-sparing surgery among young women with FIGO stage I clear cell carcinoma of the ovary.Grand multiparity and reproductive cancer in the Jerusalem Perinatal Study Cohort.Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. nurses.Hormonal and reproductive factors and the risk of ovarian cancer.Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.
P2860
Q24619808-67C1E782-B63F-4E8D-98AB-D32E3D275317Q26750772-EA683EF8-6D77-498E-809E-DD87CF7810A0Q26782803-FCE69311-A856-4BF7-989F-D5D59E18C506Q27003273-BAE3B7C0-AE12-49F4-9C9D-4FD9061AF468Q27006942-B5206106-3A4B-46A4-9DBF-89B8253C594CQ28396893-C2A265F4-2A81-4226-9099-D375C41B2956Q30855249-FE79C285-6E26-4B44-933A-5460D6C7BF2AQ33587348-EF324CCE-8EDB-439F-96C0-78BF52962FDFQ33778301-A7E9A82B-E837-4C1D-9B6A-E61A1D618871Q33779337-9CE9CFF4-4E8E-41BC-81B0-B9ABD0355595Q34372351-DEB74145-7A23-446B-B310-C9B2EBD3B119Q34460052-3315EFA1-711E-44ED-BDA8-4094D7178917Q34558361-968078C8-B978-4918-93AA-0B7419CFC8BCQ35121875-39EB4F05-59C5-4571-BBD8-3A73CBF9CAEFQ35678708-E4F10D9A-7D93-4901-9329-DE2ED13A700BQ35815412-3B1550A7-8515-4884-B371-B817D31B4017Q36054376-3F4412CA-D171-4719-BE7E-B224F7C4856EQ36153070-1AB951C6-F9CB-40B5-B87E-D500CD709A47Q36382387-0C6BD38D-17D2-4E1C-AC16-6F2B921676F8Q36671946-7693C42C-C2DE-47BF-81DE-A6802A7D4D9CQ36703320-7CA6752D-1FFA-4621-AD82-4A1A979249C4Q36790454-DCCD652F-1392-43B8-BD42-8E33EFE16FEDQ36915870-C28792A3-9EDE-4EFD-9AB5-CFCD1E781D0FQ36992167-5F71C894-130C-4486-8BE9-2FCB84A301A6Q37225222-E6A0F15D-9534-4000-B62E-A5148B58DF69Q37362164-90DBA51F-E508-4076-A8B1-7A411B67B281Q37584843-85BC9984-AF38-454C-A838-6E691674AE95Q37589506-7D8D6EB3-3F29-4B89-BB35-FB29CE66DA18Q37645709-1B2B6156-2C88-487E-99E2-8FD021994BC7Q37681721-F5846A9D-B590-4670-B74A-D44DA4DC7B10Q37685866-026459B4-68B3-4414-9026-DCEE00B76750Q37720438-BEA2D4CD-E2FC-48D1-BCAF-7D7CEE329E65Q38134907-E8C5B32D-3649-403A-8E5C-F8697AE07434Q38151508-0F60E9EE-5355-4E2C-B79D-5A60E9376C78Q38284360-50C4540B-3815-4953-9D1C-89EE478E417EQ39868756-01C16AC6-9594-4FB9-B39A-79C566F17A3AQ40210442-5C8AB931-413C-45D0-A485-05747AFB422FQ40290088-98968FA8-E18B-4D8F-AE50-B501231931E7Q40373667-D2A9278A-7FB3-457B-80AF-6335D4318A70Q45230026-FE38EDAB-36BB-4433-A1D8-FD165E81541D
P2860
Relationship of benign gynecologic diseases to subsequent risk of ovarian and uterine tumors.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Relationship of benign gynecol ...... of ovarian and uterine tumors.
@en
type
label
Relationship of benign gynecol ...... of ovarian and uterine tumors.
@en
prefLabel
Relationship of benign gynecol ...... of ovarian and uterine tumors.
@en
P2093
P50
P1476
Relationship of benign gynecol ...... of ovarian and uterine tumors.
@en
P2093
Barry I Graubard
Kirsten Frederiksen
Lori C Sakoda
Mark E Sherman
P304
P356
10.1158/1055-9965.EPI-05-0394
P577
2005-12-01T00:00:00Z